IDEXX Laboratories Aktie

IDEXX Laboratories für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN: 888210 / ISIN: US45168D1046

<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
04.08.2025 12:45:24

IDEXX Laboratories Inc Q2 Profit Increases, Beats Estimates

(RTTNews) - IDEXX Laboratories Inc (IDXX) revealed earnings for its second quarter that Increased from the same period last year and beat the Street estimates.

The company's bottom line totaled $293.99 million, or $3.63 per share. This compares with $203.30 million, or $2.44 per share, last year.

Excluding items, IDEXX Laboratories Inc reported adjusted earnings of $3.50 per share for the period.

Analysts on average had expected the company to earn $3.30 per share. Analysts' estimates typically exclude special items.

The company's revenue for the period rose 10.6% to $1.109 billion from $1.003 billion last year.

IDEXX Laboratories Inc earnings at a glance (GAAP) :

-Earnings: $293.99 Mln. vs. $203.30 Mln. last year. -EPS: $3.63 vs. $2.44 last year. -Revenue: $1.109 Bln vs. $1.003 Bln last year.

-Guidance: Full year EPS guidance: $12.40 - $12.76 Full year revenue guidance: $4,205 - $4,280 Mln

Analysen zu IDEXX Laboratoriesmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

IDEXX Laboratories 553,40 1,43% IDEXX Laboratories